Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma

Clinical trial NCT00338988 · COMPLETED

Trial details

NCT number: NCT00338988
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer of the Gallbladder Cancer of the Biliary Tract

Start date: 2003-08-01
Primary completion: 2009-05-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.